Amdocs LTD (DOX) — SEC Filings

Q: What are the key financial highlights for Amdocs LTD?

Key financial highlights for Amdocs LTD are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Amdocs LTD?

Key executives at Amdocs LTD are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Amdocs LTD stock?

Risk factors for Amdocs LTD (DOX) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Amdocs LTD?

Forward-looking statements and predictions from Amdocs LTD are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Amdocs LTD. Recent 6-K filing on Dec 16, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Amdocs LTD on SEC EDGAR

Overview

Amdocs LTD (DOX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 16, 2025: Amdocs Limited filed a Form 6-K on December 16, 2025, to report information for the month of December 2025. The filing indicates Amdocs Limited is a foreign private issuer and files annual reports under Form 20-F. The principal executive offices are located in St. Louis, Missouri, with a registered

Sentiment Summary

Across 25 filings, the sentiment breakdown is: 1 bullish, 23 neutral, 1 mixed. The dominant filing sentiment for Amdocs LTD is neutral.

Filing Type Overview

Amdocs LTD (DOX) has filed 19 6-K, 2 20-F, 4 SC 13G/A with the SEC between Feb 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (25)

Amdocs Ltd Files 6-K for December 2025 — 6-K · Dec 16, 2025 Risk: low
Amdocs Limited filed a Form 6-K on December 16, 2025, to report information for the month of December 2025. The filing indicates Amdocs Limited is a foreign pri
Amdocs Navigates Macro Headwinds, AI Integration Amidst Fierce Competition — 20-F · Dec 15, 2025 Risk: high
Amdocs Limited (DOX) reported its fiscal year ended September 30, 2025, with 108,448,276 ordinary shares outstanding, net of 181,903,009 shares held in treasury
Amdocs Reports Q4 2025 Financial Results — 6-K · Nov 12, 2025 Risk: low
Amdocs Limited announced its financial results for the quarter ended September 30, 2025, on November 11, 2025. The company filed a Form 6-K to report this infor
Amdocs Files Q3 2025 Results on Form 6-K — 6-K · Aug 18, 2025 Risk: low
Amdocs Limited filed a Form 6-K for the quarter ended June 30, 2025, reporting its financial results. The filing, submitted on August 18, 2025, confirms Amdocs'
6-K Filing — 6-K · Aug 7, 2025
Amdocs Ltd Files Q2 2025 6-K Report — 6-K · May 19, 2025 Risk: low
Amdocs Limited filed a Form 6-K for the quarter ended March 31, 2025. The filing provides information on the company's financial reporting and corporate structu
Amdocs Reports Q2 2025 Financial Results — 6-K · May 8, 2025 Risk: low
On May 7, 2025, Amdocs Limited announced its financial results for the quarter ended March 31, 2025. The company issued a press release and accompanying present
Amdocs Files Q4 2024 6-K Report — 6-K · Feb 18, 2025 Risk: low
Amdocs Limited filed a Form 6-K for the quarter ended December 31, 2024, reporting as a foreign private issuer. The filing confirms they will file annual report
Amdocs Reports Q4 2024 Financial Results — 6-K · Feb 5, 2025 Risk: low
Amdocs Limited announced its financial results for the quarter ended December 31, 2024, on February 4, 2025. The company filed a Form 6-K to report these result
Amdocs Limited Holds 2025 Annual Shareholder Meeting — 6-K · Feb 3, 2025 Risk: low
Amdocs Limited held its 2025 Annual General Meeting of Shareholders on January 31, 2025, where proposals were submitted for a vote. The company's principal exec
Amdocs Ltd Files 6-K for December 2024 — 6-K · Dec 23, 2024 Risk: low
Amdocs Limited filed a Form 6-K on December 23, 2024, to report for the month of December 2024. The filing indicates that Amdocs Limited is a foreign private is
Amdocs Files 2024 Annual Report — 6-K · Dec 18, 2024 Risk: low
On December 18, 2024, Amdocs Limited filed its annual report for the fiscal year ended September 30, 2024, as an exhibit to its Form 6-K filing with the SEC. Th
Amdocs Ltd. 20-F Filing: Acquisitions and Dividend Update — 20-F · Dec 17, 2024 Risk: medium
Amdocs Ltd. filed its 20-F report for the fiscal year ending September 30, 2024. The company's fiscal year runs from October 1st to September 30th. Amdocs compl
SC 13G/A Filing — SC 13G/A · Nov 14, 2024
Amdocs Reports Q4 2024 Financial Results — 6-K · Nov 13, 2024 Risk: low
On November 12, 2024, Amdocs Limited announced its financial results for the quarter ended September 30, 2024. The company issued a press release and accompanyi
Amdocs Ltd Files Q3 2024 Results on Form 6-K — 6-K · Aug 19, 2024 Risk: low
Amdocs Limited filed a Form 6-K for the quarter ended June 30, 2024, reporting its financial results. The filing indicates Amdocs Limited is a foreign private i
Amdocs Reports Q3 2024 Financial Results — 6-K · Aug 8, 2024 Risk: low
Amdocs Limited announced its financial results for the quarter ended June 30, 2024, on August 7, 2024. The company issued a press release and accompanying prese
Amdocs Limited Files Q2 2024 6-K Report — 6-K · May 20, 2024 Risk: low
Amdocs Limited filed a Form 6-K for the quarter ended March 31, 2024, reporting its financial results. The company is incorporated in Guernsey and has its princ
Amdocs Reports Q2 2024 Financial Results — 6-K · May 9, 2024 Risk: low
On May 8, 2024, Amdocs Limited announced its financial results for the quarter ended March 31, 2024. The company issued a press release and accompanying present
Amdocs Files 6-K for Q4 2023, Confirms 20-F Annual Reporting — 6-K · Feb 20, 2024 Risk: low
Amdocs Ltd. filed a Form 6-K with the SEC on February 20, 2024, for the quarter ended December 31, 2023. The filing indicates Amdocs, a foreign private issuer,
SC 13G/A Filing — SC 13G/A · Feb 13, 2024
FMR LLC & Abigail Johnson Hold 14.977% Stake in Amdocs Ltd. — SC 13G/A · Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Amdocs Ltd. (DOX) through an SC 13G/A filin
MFS Amends Amdocs Stake: Reports Sole Voting Power Over 691,131 Shares — SC 13G/A · Feb 9, 2024 Risk: low
Massachusetts Financial Services Company (MFS) filed an amended SC 13G/A for Amdocs Ltd, indicating a change in their beneficial ownership as of December 29, 20
Amdocs Reports Record Q1 Revenue of $1.25B, 5% YoY Growth — 6-K · Feb 7, 2024
Amdocs Limited announced record quarterly revenue of $1.25 billion for the quarter ended December 31, 2023, representing a roughly 5% year-over-year increase bo
Amdocs Shareholders Re-Elect All 10 Board Nominees at 2024 AGM — 6-K · Feb 5, 2024
Amdocs Ltd. held its 2024 Annual General Meeting of Shareholders on February 2, 2024, where shareholders voted on the election of ten nominees to the Board of D

Risk Profile

Risk Assessment: Of DOX's 20 recent filings, 1 were flagged as high-risk, 1 as medium-risk, and 18 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

Matthew E. Smith
Abigail P. Johnson
December 29, 2023

Industry Context

Amdocs operates within the communications industry, a sector characterized by intense competition from various players including independent software vendors, in-house IT departments, and network equipment manufacturers. The industry is undergoing rapid technological shifts driven by 5G, cloud computing, and AI, demanding continuous innovation from service providers and their technology partners.

Top Tags

financial-results (8) · earnings (7) · sec-filing (7) · quarterly-report (3) · foreign-private-issuer (2) · 6-k (2) · filing (2) · shareholder-meeting (2) · corporate-governance (2) · foreign-issuer (2)

Key Numbers

Ordinary Shares Outstanding: 108,448,276 — As of September 30, 2025, net of treasury shares, indicating current equity structure.
Shares Held in Treasury: 181,903,009 — As of September 30, 2025, impacting the net outstanding shares.
Ordinary Shares Reserved: 1,538,557 — For issuance upon exercise of stock options and vesting of restricted stock units, indicating potential future dilution.
Par Value per Ordinary Share: $0.01 — The nominal value of each ordinary share.
Fiscal Year End: September 30, 2025 — The period covered by this annual report.
Acquisitions: 2 — Completed in December 2019 and December 2022.
Filing Date: 2024-12-17 — The date this 20-F was submitted to the SEC.
Shares Beneficially Owned: 17,510,389 — Represents the total common stock of Amdocs Ltd. held by FMR LLC and Abigail P. Johnson.
Percent of Class: 14.977% — Indicates the significant portion of Amdocs Ltd. that FMR LLC and Abigail P. Johnson collectively own.
Shares with Sole Voting Power: 691,131 — Represents the number of Amdocs Ltd shares Massachusetts Financial Services Company can vote independently.

Forward-Looking Statements

{"claim":"FMR LLC will maintain a significant, passive ownership stake in Amdocs Ltd. for the foreseeable future.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"high"}

Frequently Asked Questions

What are the latest SEC filings for Amdocs LTD (DOX)?

Amdocs LTD has 25 recent SEC filings from Feb 2024 to Dec 2025, including 19 6-K, 4 SC 13G/A, 2 20-F. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of DOX filings?

Across 25 filings, the sentiment breakdown is: 1 bullish, 23 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Amdocs LTD SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Amdocs LTD (DOX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Amdocs LTD?

Financial highlights for Amdocs LTD are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for DOX?

The investment thesis for DOX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Amdocs LTD?

Key executives identified across Amdocs LTD's filings include Matthew E. Smith, Abigail P. Johnson, December 29, 2023.

What are the main risk factors for Amdocs LTD stock?

Of DOX's 20 assessed filings, 1 were flagged high-risk, 1 medium-risk, and 18 low-risk.

What are recent predictions and forward guidance from Amdocs LTD?

Recent forward-looking statements from Amdocs LTD include guidance on {"claim":"FMR LLC will maintain a significant, passive ownership stake in Amdocs Ltd. for the foreseeable future.","enti.